Influenza Vaccination for Secondary Prevention of Cardiovascular Events: A Systematic Review.

ABSTRACT:

Background

Influenza is a common respiratory infection that may cause complications, including cardiovascular events. Influenza illness has been shown to double the risk of myocardial infarction, with the highest risk among patients with established cardiovascular disease. Vaccination against influenza has been associated with reductions in myocardial infarction, cerebrovascular disease, and death.

Objective

To evaluate the evidence for influenza vaccination as a strategy to reduce cardiovascular events specifically in patients with established cardiovascular disease.

Data sources and study selection

MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were searched with the terms "influenza vaccine" and "cardiovascular disease". Included in this re

SUBMITTER: LeBras MH 

PROVIDER: S-EPMC5358055 | biostudies-literature | 2017 Jan-Feb

REPOSITORIES: biostudies-literature